Animal Models of Osteoarthritis: Challenges of Model Selection and Analysis
Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 2
Abstract
Osteoarthritis (OA) is the most common musculoskeletal disease, affecting millions of individuals worldwide. New treatment approaches require an understanding of the pathophysiology of OA and its biomechanical, inflammatory, genetic, and environmental risk factors. The purpose of animal models of OA is to reproduce the pattern and progression of degenerative damage in a controlled fashion, so that opportunities to monitor and modulate symptoms and disease progression can be identified and new therapies developed. This review discusses the features, strengths, and weaknesses of the common animal models of OA; considerations to be taken when choosing a method for experimental induction of joint degeneration; and the challenges of measuring of OA progression and symptoms in these models.
Authors and Affiliations
Erin Teeple, Gregory D. Jay, Khaled A. Elsaid, Braden C. Fleming
Keywords
Related Articles
- EP ID EP681113
- DOI 10.1208/s12248-013-9454-x
- Views 59
- Downloads 0
Pharmacokinetic Interactions for Drugs with a Long Half-Life—Evidence for the Need of Model-Based Analysis
The online version of this article (doi:10.1208/s12248-015-9829-2) contains supplementary material, which is available to authorized users.
Influence of Surface Chemistry on Cytotoxicity and Cellular Uptake of Nanocapsules in Breast Cancer and Phagocytic Cells
The online version of this article (doi:10.1208/s12248-014-9572-0) contains supplementary material, which is available to authorized users.
Erratum to: Modeling the Effects of Vaccination and Treatment on Pandemic Influenza
The online version of the original article can be found at 10.1208/s12248-011-9284-7.
Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations
Interleukin-1 beta (IL-1β) is an inflammatory mediator which may contribute to the pathophysiology of rheumatoid arthritis (RA) and type 2 diabetes mellitus (T2DM). Population pharmacokinetics (PK) of LY2189102,...
The Role of Megalin in the Transport of Gentamicin Across BeWo Cells, an In Vitro Model of the Human Placenta
Aminoglycosides (AG) are known to readily cross the placenta, although the mechanisms responsible for placental transport have not been characterized. Megalin is expressed in human placenta, and it is reasonable to specu...